Purpose This review provides an update on the current clinical, epidemiological and
pathophysiological evidence alongside the diagnostic, prevention and treatment approach …

Chemotherapy‐induced peripheral neuropathy (CIPN) is a common dose‐limiting side effect
experienced by patients receiving treatment for cancer. Approximately 30 to 40% of patients …

Chemotherapy-induced neuropathy is a common, dose-dependent adverse effect of several
antineoplastics. It can lead to detrimental dose reductions and discontinuation of treatment …

With a 3‐fold increase in the number of cancer survivors noted since the 1970s, there are
now over 28 million cancer survivors worldwide. Accordingly, there is a heightened …

Neurotoxic anticancer drugs, such as platinum-based anticancer drugs, taxanes, vinca
alkaloids, and proteasome/angiogenesis inhibitors are responsible for chemotherapy …

The peripheral nervous system can be vulnerable to the toxic action of several drugs since it
is not protected as effectively as the central nervous system from noxious exogenous agents …

Background The objective of this study was to systematically review all available literature
concerning chemotherapy-induced peripheral neuropathy (CIPN) and quality of life (QOL) …

Introduction Peripheral neuropathies are a prevalent, heterogeneous group of diseases of
the peripheral nervous system. Symptoms are often debilitating, difficult to treat, and usually …

Vincristine is a chemotherapeutic agent that is a component of many combination regimens
for a variety of malignancies, including several common pediatric tumors. Vincristine …

Vincristine-induced peripheral neuropathy (VIPN) is a dose-limiting side effect of vincristine
(VCR) treatment in children, leading to diminished quality of life. Much remains unknown …